Human Umbilical Cord Mesenchymal Stem Cells(Guangzhou Women & Childrens Medical Center)(Human Umbilical Cord Mesenchymal Stem Cells(Guangzhou Women & Childrens Medical Center))

概要

基本信息

药物类型

间充质干细胞疗法

别名-

靶点-

作用机制-

治疗领域

遗传病与畸形皮肤和肌肉骨骼疾病泌尿生殖系统疾病+ [1]

在研适应症

Alport 综合征

非在研适应症-

原研机构

广州市妇女儿童医疗中心

在研机构

广州市妇女儿童医疗中心

非在研机构-

最高研发阶段临床2/3期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

1

项与 Human Umbilical Cord Mesenchymal Stem Cells(Guangzhou Women & Childrens Medical Center) 相关的临床试验

NCT06731192

/ Not yet recruiting临床2/3期IIT

Human Umbilical Cord Mesenchymal Stem Cells for Alport Syndrome: Α Prospective Randomized, Single-blind, Placebo-controlled, Single-center Clinical Trial

The goal of this clinical trial is to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells (hUC-MSC) in the treatment of Alport syndrome (AS) in a randomized, single-blind, placebo-controlled trial, to provide a clinical basis for the development of stem cell products for the treatment of AS, and to further clarify the therapeutic effect of hUC-MSC in the treatment of AS.

开始日期2025-01-01

申办/合作机构

广州市妇女儿童医疗中心

100 项与 Human Umbilical Cord Mesenchymal Stem Cells(Guangzhou Women & Childrens Medical Center) 相关的临床结果

登录后查看更多信息

100 项与 Human Umbilical Cord Mesenchymal Stem Cells(Guangzhou Women & Childrens Medical Center) 相关的转化医学

登录后查看更多信息

100 项与 Human Umbilical Cord Mesenchymal Stem Cells(Guangzhou Women & Childrens Medical Center) 相关的专利（医药）

登录后查看更多信息

100 项与 Human Umbilical Cord Mesenchymal Stem Cells(Guangzhou Women & Childrens Medical Center) 相关的药物交易

登录后查看更多信息